Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP455292.RAeFhgTMhjlskKzEj9eHbHl6hY9sH5xQa2NWP0enzgcfg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP455292.RAeFhgTMhjlskKzEj9eHbHl6hY9sH5xQa2NWP0enzgcfg130_assertion type Assertion NP455292.RAeFhgTMhjlskKzEj9eHbHl6hY9sH5xQa2NWP0enzgcfg130_head.
- NP455292.RAeFhgTMhjlskKzEj9eHbHl6hY9sH5xQa2NWP0enzgcfg130_assertion description "[MCPyV DNA-positive cancers contained higher numbers of CD3(+), CD8(+), CD16(+), FoxP3(+), and CD68(+) cells as compared with MCPyV DNA-negative carcinomas (all P values < 0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP455292.RAeFhgTMhjlskKzEj9eHbHl6hY9sH5xQa2NWP0enzgcfg130_provenance.
- NP455292.RAeFhgTMhjlskKzEj9eHbHl6hY9sH5xQa2NWP0enzgcfg130_assertion evidence source_evidence_literature NP455292.RAeFhgTMhjlskKzEj9eHbHl6hY9sH5xQa2NWP0enzgcfg130_provenance.
- NP455292.RAeFhgTMhjlskKzEj9eHbHl6hY9sH5xQa2NWP0enzgcfg130_assertion SIO_000772 22467679 NP455292.RAeFhgTMhjlskKzEj9eHbHl6hY9sH5xQa2NWP0enzgcfg130_provenance.
- NP455292.RAeFhgTMhjlskKzEj9eHbHl6hY9sH5xQa2NWP0enzgcfg130_assertion wasDerivedFrom befree-20140225 NP455292.RAeFhgTMhjlskKzEj9eHbHl6hY9sH5xQa2NWP0enzgcfg130_provenance.
- NP455292.RAeFhgTMhjlskKzEj9eHbHl6hY9sH5xQa2NWP0enzgcfg130_assertion wasGeneratedBy ECO_0000203 NP455292.RAeFhgTMhjlskKzEj9eHbHl6hY9sH5xQa2NWP0enzgcfg130_provenance.